Fundz

CG Oncology Appoints Jim DeTore as Chief Financial Officer

PUBLIC · CGONApr 13, 2026

Position

Chief Financial Officer

Company

CG Oncology

Jim DeTore
IrvineBiotechnologyHealth CareTherapeutics

Description

CG Oncology has appointed Jim DeTore as its new Chief Financial Officer, effective April 13, 2026. DeTore brings extensive experience in finance and leadership from his previous roles.

Quick answer

CG Oncology Appoints Jim DeTore as Chief Financial Officer (April 13, 2026). CG Oncology is based in Irvine, California, United States.

Who is the new Chief Financial Officer at CG Oncology?
CG Oncology named Jim DeTore Chief Financial Officer, announced April 13, 2026.
What did CG Oncology announce on April 13, 2026?
CG Oncology has appointed Jim DeTore as its new Chief Financial Officer, effective April 13, 2026. DeTore brings extensive experience in finance and leadership from his previous roles.
What does CG Oncology do?
CG Oncology is a privately held oncolytic immunotherapy company focused on developing bladder-saving therapeutics for patients with bladder cancer.
Where is CG Oncology based?
CG Oncology is based in Irvine, California, United States.
Which similar companies made leadership changes around the same time?
NRx Pharmaceuticals (April 13, 2026), Abivax (April 12, 2026), Juvisé Pharmaceuticals (April 16, 2026) and Pelthos Therapeutics (April 10, 2026) also announced leadership changes within 45 days of CG Oncology.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at CG Oncology, and when

A new leader at CG Oncology brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day CG Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CG Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CG Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CG Oncology

Location

Irvine, California, United States

About

CG Oncology is a privately held oncolytic immunotherapy company focused on developing bladder-saving therapeutics for patients with bladder cancer. At CG Oncology we see a world where urologic cancer patients can benefit from our innovative therapies to live and work with dignity and an enhanced quality of life. Our lead candidate, CG0070, is an intravesically delivered oncolytic immunotherapy agent in a Phase 3 trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. CG0070 is also in a Phase 2 study in combination with KEYTRUDA® (pembrolizumab) in the same indication. Other types of bladder cancer are being evaluated with CG0070 in combination with OPDIVO® (nivolumab).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CG Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ambaw
Senior decision-maker at this company
••••••••@••••••••

See Ambaw's verified email →

Aman
Senior decision-maker at this company
••••••••@••••••••

See Aman's verified email →

Isabel
Likely contact at this company
••••••••@••••••••

See Isabel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CG Oncology's next move

Learn about Strategic plan

CG Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.